Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Clinical trial NCT06970951 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06970951
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Rheumatoid Arthritis Dry Syndrome Idiopathic Inflammatory Myopathies Systemic Sclerosis

Start date: 2025-05-18
Primary completion: 2026-06-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.